Home Cart 0 Sign in  
X

[ CAS No. 174074-88-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 174074-88-5
Chemical Structure| 174074-88-5
Chemical Structure| 174074-88-5
Structure of 174074-88-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 174074-88-5 ]

Related Doc. of [ 174074-88-5 ]

Alternatived Products of [ 174074-88-5 ]

Product Details of [ 174074-88-5 ]

CAS No. :174074-88-5 MDL No. :MFCD12031312
Formula : C10H8N2O4 Boiling Point : -
Linear Structure Formula :- InChI Key :CZKCZHGGECJJMQ-UHFFFAOYSA-N
M.W : 220.18 Pubchem ID :21505196
Synonyms :

Calculated chemistry of [ 174074-88-5 ]

Physicochemical Properties

Num. heavy atoms : 16
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.1
Num. rotatable bonds : 2
Num. H-bond acceptors : 4.0
Num. H-bond donors : 2.0
Molar Refractivity : 56.47
TPSA : 92.02 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.2 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.34
Log Po/w (XLOGP3) : 0.62
Log Po/w (WLOGP) : 0.0
Log Po/w (MLOGP) : 0.58
Log Po/w (SILICOS-IT) : 2.05
Consensus Log Po/w : 0.92

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.93
Solubility : 2.61 mg/ml ; 0.0119 mol/l
Class : Very soluble
Log S (Ali) : -2.13
Solubility : 1.64 mg/ml ; 0.00746 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.23
Solubility : 0.131 mg/ml ; 0.000593 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.79

Safety of [ 174074-88-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 174074-88-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 174074-88-5 ]
  • Downstream synthetic route of [ 174074-88-5 ]

[ 174074-88-5 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 174074-88-5 ]
  • [ 174074-89-6 ]
YieldReaction ConditionsOperation in experiment
59%
Stage #1: Heating / reflux
Stage #2: With sodium hydrogencarbonate In dichloromethane; water at 20℃; for 1 h;
To a 250 mL flask charged with methyl 2,4-dihydroxyquinazoline-7-carboxylate was added POCI3(76 mL), PCI5 (12.1 g, 58.1 mmol), and the suspension heated at reflux overnight under nitrogen. In morning a dark orange solution has formed. The POCI3 was removed and the residue azeotroped with toluene to yield an orange solid that was taken into DCM (50 mL) and added slowly to stirred satd NaHCO3 (300 mL). The bi-phasic solution was then diluted with DCM (100 mL) and water (30 mL) and stirred for 1 hour at room temp. DCM (500 mL) was added and the mix transferred to a sep-funnel. The DCM layer was removed along with a large amount of ppt. The aq. was extracted with DCM ( 3 x 100 mL) and the combined organics dried over MgSO4, filtered and stripped to a orange solid that was purified by Biotage 65 flash chromatography eluting with DCM - 3percent MeOH/DCM over 3.5 L to reveal the title compound as a white solid, 4.4 g, 59percent.1H NMR (400 MHz, DMSO-D6) δ ppm 8.47 (1 H, d, J=1.01 Hz) 8.43 (1 H, d, J=8.84 Hz) 8.29 (1 H, dd, J=8.72, 1.64 Hz) 3.96 (3 H, s); MS (API+) for C10H6N2CI2O2 m/z 257.0 (M+H)+.
Reference: [1] Patent: WO2007/125405, 2007, A2, . Location in patent: Page/Page column 20; 48-49; 54
  • 2
  • [ 174074-88-5 ]
  • [ 174074-89-6 ]
Reference: [1] Patent: WO2004/78733, 2004, A1, . Location in patent: Page 424
[2] Patent: WO2012/58671, 2012, A1, . Location in patent: Page/Page column 113
  • 3
  • [ 60-35-5 ]
  • [ 5372-81-6 ]
  • [ 174074-88-5 ]
YieldReaction ConditionsOperation in experiment
80% at 200℃; for 3 h; Step 1: 2,4-Dioxo-l,2,3,4-tetrahydro-quinazoline-7-carboxylic acid methyl esterTo a 250 mL round bottom flask, 2-amino dimethyl terephthalate (3 g, 0.0143 mol) and urea (4.3 g, 0.0717 mol) were added. The reaction mixture was stirred at 200°C for 3 h. The reaction mixture was allowed to reach 100 °C and water was added. The aqueous reaction mixture was stirred at 100°C for 5-10 min then allowed to reach room temperature. The solid was filtered, washed with chloroform dried and azeotroped with toluene to afford the title compound [2.5 g, 80percent]. This material was taken to the next step without any further purification. 1H NMR; (400 MHz, DMSO-d6): δ 11.25 (brs, 2H), 7.98 (d, 1H, J= 8.2 Hz), 7.78 (s, 1H), 7.65 (d, J= 8.2, 1.2 Hz, 1H), 3.98 (s, 3H): LC-MS (ESI): Calculated mass: 220.0; Observed mass: 221.0 [M+H]+ (RT: 0.19 min)
Reference: [1] Patent: WO2012/58671, 2012, A1, . Location in patent: Page/Page column 112-113
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 174074-88-5 ]

Amides

Chemical Structure| 61948-86-5

[ 61948-86-5 ]

5-Methoxyquinazoline-2,4(1H,3H)-dione

Similarity: 0.83

Chemical Structure| 860187-45-7

[ 860187-45-7 ]

Methyl 2-oxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylate

Similarity: 0.82

Chemical Structure| 3814-10-6

[ 3814-10-6 ]

Methyl 4-(phenylcarbamoyl)benzoate

Similarity: 0.82

Chemical Structure| 86-96-4

[ 86-96-4 ]

Quinazoline-2,4(1H,3H)-dione

Similarity: 0.81

Chemical Structure| 59674-85-0

[ 59674-85-0 ]

7-Aminoquinazoline-2,4(1H,3H)-dione

Similarity: 0.81

Esters

Chemical Structure| 860187-45-7

[ 860187-45-7 ]

Methyl 2-oxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylate

Similarity: 0.82

Chemical Structure| 3814-10-6

[ 3814-10-6 ]

Methyl 4-(phenylcarbamoyl)benzoate

Similarity: 0.82

Chemical Structure| 106429-57-6

[ 106429-57-6 ]

Methyl 2-oxo-2,3-dihydro-1H-benzo[d]imidazole-5-carboxylate

Similarity: 0.78

Chemical Structure| 301533-59-5

[ 301533-59-5 ]

Methyl 4-butyramido-3-methylbenzoate

Similarity: 0.76

Chemical Structure| 5395-36-8

[ 5395-36-8 ]

Ethyl 6-methyl-2-oxo-4-phenyl-1,2,3,4-tetrahydropyrimidine-5-carboxylate

Similarity: 0.75

Related Parent Nucleus of
[ 174074-88-5 ]

Quinazolines

Chemical Structure| 61948-86-5

[ 61948-86-5 ]

5-Methoxyquinazoline-2,4(1H,3H)-dione

Similarity: 0.83

Chemical Structure| 86-96-4

[ 86-96-4 ]

Quinazoline-2,4(1H,3H)-dione

Similarity: 0.81

Chemical Structure| 59674-85-0

[ 59674-85-0 ]

7-Aminoquinazoline-2,4(1H,3H)-dione

Similarity: 0.81

Chemical Structure| 67449-23-4

[ 67449-23-4 ]

8-Methylquinazoline-2,4(1H,3H)-dione

Similarity: 0.80

Chemical Structure| 604-50-2

[ 604-50-2 ]

1-Methylquinazoline-2,4(1H,3H)-dione

Similarity: 0.77